Traws Pharma, Inc. Share Price Today: Live Updates & Key Insights
Traws Pharma, Inc. share price today is $2.1, up -1.83%. The stock opened at $2.13 against the previous close of $2.18, with an intraday high of $2.18 and low of $2.09.
Traws Pharma, Inc. Share Price Chart
Traws Pharma, Inc.
Traws Pharma, Inc. Share Price Performance
Traws Pharma, Inc. Institutional Holdings
Traws Pharma, Inc. Market Status
Traws Pharma, Inc. Fundamentals
Market Cap 19.42 M
PB Ratio 3.7097
PE Ratio 0.0
Enterprise Value 10.44 M
Total Assets 24.96 M
Volume 58486
Traws Pharma, Inc. Company Financials
About Traws Pharma, Inc. & investment objective
Company Information Traws Pharma, Inc., a clinical-stage biopharmaceutical company, develops small-molecule oral product candidates for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and COVID-19 that are designed to address treatment resistance, such as TRX01 (Ratutrelvir), an inhibitor in development for the treatment of COVID-19; and Tivoxavir marboxil, an endonuclease inhibitor in development for the treatment of bird flu and seasonal influenza. It is also developing narazaciclib, a multi-targeted kinase inhibitor in solid tumors and hematological malignancies as a single agent or in combination with other anti-cancer therapies; and rigosertib, which is administered alone or in combination for investigation in various cancers. It has a license agreement with SymBio Pharmaceuticals Limited, Pint International SA, Viriom, Inc., and Temple University. The company was formerly known as Onconova Therapeutics, Inc. and changed its name to Traws Pharma, Inc. in April 2024. Traws Pharma, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania.
Organisation Biotechnology
Employees 6
Industry Biotechnology
CEO Dr. Iain D. Dukes DPHIL, M.A., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Traws Pharma, Inc. FAQs
What is the share price of Traws Pharma, Inc. today?
The current share price of Traws Pharma, Inc. is $2.1.
Can I buy Traws Pharma, Inc. shares in India?
Yes, Indian investors can buy Traws Pharma, Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Traws Pharma, Inc. shares in India?
You can easily invest in Traws Pharma, Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Traws Pharma, Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Traws Pharma, Inc..
Can I buy fractional shares of Traws Pharma, Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Traws Pharma, Inc.?
Traws Pharma, Inc. has a market cap of $19.42 M.
In which sector does Traws Pharma, Inc. belong?
Traws Pharma, Inc. operates in the Biotechnology sector.
What documents are required to invest in Traws Pharma, Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Traws Pharma, Inc.?
The PE ratio of Traws Pharma, Inc. is N/A and the PB ratio is 3.71.